Postpartum pElvic Assisted Recovery With Leva
PEARL
Feasibility of Pelvic Floor Muscle Training With a Digital Therapeutic Motion-based Device (Leva Device) in a Postpartum Population
1 other identifier
interventional
25
1 country
2
Brief Summary
The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device. In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum. Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2024
CompletedFirst Posted
Study publicly available on registry
September 24, 2024
CompletedStudy Start
First participant enrolled
April 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJuly 29, 2025
July 1, 2025
7 months
September 20, 2024
July 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility
Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.
From enrollment to 6 months postpartum
Perineal Pain
Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.
From enrollment to 6 months postpartum
Secondary Outcomes (5)
Bladder function
From enrollment to 6 months postpartum
Bowel Function
From enrollment to 6 months postpartum
Pelvic Organ Prolapse
From enrollment to 6 months postpartum
Vaginal pain
From enrollment to 6 months postpartum
Sexual function
From enrollment to 6 months postpartum
Study Arms (1)
Device Arm
EXPERIMENTALParticipants in this arm will use a digital therapeutic motion-based device for postpartum pelvic floor muscle training
Interventions
This intervention includes use of a digital therapeutic motion-based device for pelvic floor muscle training
Eligibility Criteria
You may qualify if:
- Spontaneous vaginal delivery within the last 4-8 weeks
- Age ≥ 18 years
- Ambulatory
- Willing and able to consent to participate.
- English speaking
- Owns a smartphone
You may not qualify if:
- Operative or cesarean delivery
- Obstetric delivery at less than 20 weeks gestation
- Third- or fourth-degree perineal laceration
- Episiotomy
- Multiples
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of South Florida
Tampa, Florida, 33606, United States
Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2024
First Posted
September 24, 2024
Study Start
April 4, 2025
Primary Completion
November 1, 2025
Study Completion
February 1, 2026
Last Updated
July 29, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share